A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Synovial Sarcoma, Cancer, Soft Tissue Sarcoma, Sarcoma, Metastatic Sarcoma
In brief
To assess if the CMB305 vaccine regimen may help the body's immune system to slow or stop the growth of synovial sarcoma tumor and improve survival.
Key facts
- Study ID
- NCT03520959
- Run by
- Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- People needed
- 1
- Starts
- 2018-09-18
- Expected to finish
- 2018-11-20
- Last updated by the study team
- 2020-04-16
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic- Scottsdale — Scottsdale, Arizona, United States
- University of Arizona Cancer Center — Tucson, Arizona, United States
- USC Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Stanford University — Palo Alto, California, United States
- Sarcoma Oncology Center — Santa Monica, California, United States
- University of Colorado Cancer Center — Boulder, Colorado, United States
- Yale University School of Medicine- Cancer Center — New Haven, Connecticut, United States
- University of Miami — Coral Gables, Florida, United States
- Mayo Clinic- Jacksonville — Jacksonville, Florida, United States
- Moffitt Cancer Center at USF — Tampa, Florida, United States
- Northwestern — Chicago, Illinois, United States
- Dana Farber Cancer Institute/Mass General Hospital — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Washington University in St. Louis — St Louis, Missouri, United States
- Nebraska Methodist Hospital — Omaha, Nebraska, United States
- Hackensack University Medical Center — Edison, New Jersey, United States
- Cohen Children's Medical Center (Northwell) — Astoria, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Duke University — Durham, North Carolina, United States
- Cincinnati Children's Hospital — Cincinnati, Ohio, United States
- Ohio State University — Columbus, Ohio, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.